123 related articles for article (PubMed ID: 8817726)
1. The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles.
Raven PW; O'Dwyer AM; Taylor NF; Checkley SA
Psychoneuroendocrinology; 1996 Apr; 21(3):277-86. PubMed ID: 8817726
[TBL] [Abstract][Full Text] [Related]
2. Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11 beta-hydroxysteroid dehydrogenase: a model for 11-HSD I deficiency.
Raven PW; Checkley SA; Taylor NF
Clin Endocrinol (Oxf); 1995 Nov; 43(5):637-44. PubMed ID: 8548950
[TBL] [Abstract][Full Text] [Related]
3. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
4. Treatment of major depression with metyrapone and hydrocortisone.
O'Dwyer AM; Lightman SL; Marks MN; Checkley SA
J Affect Disord; 1995 Feb; 33(2):123-8. PubMed ID: 7759660
[TBL] [Abstract][Full Text] [Related]
5. Response to steroid suppression in major depression resistant to antidepressant therapy.
Murphy BE; Dhar V; Ghadirian AM; Chouinard G; Keller R
J Clin Psychopharmacol; 1991 Apr; 11(2):121-6. PubMed ID: 1829098
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
Murphy BE; Ghadirian AM; Dhar V
Can J Psychiatry; 1998 Apr; 43(3):279-86. PubMed ID: 9561317
[TBL] [Abstract][Full Text] [Related]
7. Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers.
Rupprecht R; Ströhle A; Hermann B; di Michele F; Spalletta G; Pasini A; Holsboer F; Romeo E
Biol Psychiatry; 1998 Nov; 44(9):912-4. PubMed ID: 9807647
[TBL] [Abstract][Full Text] [Related]
8. The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls.
Goodwin GM; Muir WJ; Seckl JR; Bennie J; Carroll S; Dick H; Fink G
J Affect Disord; 1992 Oct; 26(2):73-83. PubMed ID: 1332993
[TBL] [Abstract][Full Text] [Related]
9. Metyrapone improves endothelial dysfunction in patients with treated depression.
Broadley AJ; Korszun A; Abdelaal E; Moskvina V; Deanfield J; Jones CJ; Frenneaux MP
J Am Coll Cardiol; 2006 Jul; 48(1):170-5. PubMed ID: 16814663
[TBL] [Abstract][Full Text] [Related]
10. Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion.
Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
Biol Psychiatry; 1997 Jun; 41(12):1149-55. PubMed ID: 9171905
[TBL] [Abstract][Full Text] [Related]
11. Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment.
von Bardeleben U; Stalla GK; Müller OA; Holsboer F
Biol Psychiatry; 1988 Nov; 24(7):782-6. PubMed ID: 2852510
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone.
Monaghan PJ; Owen LJ; Trainer PJ; Brabant G; Keevil BG; Darby D
Ann Clin Biochem; 2011 Sep; 48(Pt 5):441-6. PubMed ID: 21813575
[TBL] [Abstract][Full Text] [Related]
13. Assessment of hypothalamic-pituitary-adrenocortical axis function in dexamethasone treated very low birth weight infants by a single dose metyrapone test and gas chromatographic mass spectrometric determination of urinary steroids.
Wudy SA; Homoki J; Haack D; Jung D; Sorgo W; Teller WM; Bartman P
J Pediatr Endocrinol Metab; 1995; 8(4):281-6. PubMed ID: 8821906
[TBL] [Abstract][Full Text] [Related]
14. 20-Dihydroisomers of cortisol and cortisone in human urine: excretion rates under different physiological conditions.
Eisenschmid B; Heilmann P; Oelkers W; Rejaibi R; Schöneshöfer M
J Clin Chem Clin Biochem; 1987 Jun; 25(6):345-9. PubMed ID: 3625132
[TBL] [Abstract][Full Text] [Related]
15. Cortisol measurement in patients receiving metyrapone therapy.
Owen LJ; Halsall DJ; Keevil BG
Ann Clin Biochem; 2010 Nov; 47(Pt 6):573-5. PubMed ID: 20926474
[TBL] [Abstract][Full Text] [Related]
16. Physiological and drug-induced changes in blood levels of adrenal steroids and their precursors in cynomolgus monkeys: An application of steroid profiling by LC-MS/MS for evaluation of the adrenal toxicity.
Tochitani T; Yamashita A; Matsumoto I; Kouchi M; Fujii Y; Yamada T; Miyawaki I
J Toxicol Sci; 2019; 44(9):575-584. PubMed ID: 31474739
[TBL] [Abstract][Full Text] [Related]
17. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
Koutkia P; Berry J; Eaton K; Breu J; Grinspoon S
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
[TBL] [Abstract][Full Text] [Related]
19. Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome.
Vega-Beyhart A; Laguna-Moreno J; Díaz-Catalán D; Boswell L; Mora M; Halperin I; Casals G; Hanzu FA
Front Endocrinol (Lausanne); 2022; 13():833644. PubMed ID: 35282465
[TBL] [Abstract][Full Text] [Related]
20. Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone.
Rupprecht R; Kornhuber J; Wodarz N; Lugauer J; Göbel C; Haack D; Beck G; Müller OA; Riederer P; Beckmann H
Biol Psychiatry; 1991 Jun; 29(11):1099-109. PubMed ID: 1651773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
